MUC1-C in chronic inflammation and carcinogenesis; emergence as a target for cancer treatment | Zendy

Donald Küfe | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

MUC1-C in chronic inflammation and carcinogenesis; emergence as a target for cancer treatment

Author(s) -

Donald Küfe

Publication year - 2020

Publication title -

carcinogenesis

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.688

H-Index - 204

eISSN - 1460-2180

pISSN - 0143-3334

DOI - 10.1093/carcin/bgaa082

Subject(s) - inflammation , cancer , carcinogenesis , reprogramming , epigenetics , immune system , biology , immunology , cancer research , cancer prevention , medicine , gene , genetics

Chronic inflammation is a highly prevalent consequence of changes in environmental and lifestyle factors that contribute to the development of cancer. The basis for this critical association has largely remained unclear. The MUC1 gene evolved in mammals to protect epithelia from the external environment. The MUC1-C subunit promotes responses found in wound healing and cancer. MUC1-C induces EMT, epigenetic reprogramming, dedifferentiation and pluripotency factor expression, which when prolonged in chronic inflammation promote cancer progression. As discussed in this review, MUC1-C also drives drug resistance and immune evasion, and is an important target for cancer therapeutics now under development.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research